NALPROPION PHARMACEUTICALS INC has a total of 19 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, machines and computer technology are SMITH HOWARD J & ASS PTY LTD, ARTURO JIMENEZ BAYARDO and PENWEST PHARMACEUTICALS COMPAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Australia | 1 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Control | |
#6 | Medical technology | |
#7 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Mckinney Anthony A | 8 |
#2 | Tollefson Gary | 7 |
#3 | Weber Eckard | 5 |
#4 | Klassen Preston | 4 |
#5 | Taylor Kristin | 4 |
#6 | Dunayevich Eduardo | 4 |
#7 | Dunzo Thea Elise | 3 |
#8 | Soltero Rick | 3 |
#9 | Soltero Richard | 3 |
#10 | Tollefson Gary D | 3 |
Publication | Filing date | Title |
---|---|---|
US2019358222A1 | Increasing Drug Bioavailability In Naltrexone Therapy | |
EP3626236A1 | Sustained release formulation of naltrexone |